Stay updated on Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, signaling a minor update to the page version.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a minor maintenance update to the ClinicalTrials.gov entry; no study details or results were affected.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page footer revision version was updated from v3.5.2 to v3.5.3, indicating a minor ClinicalTrials.gov site version change rather than a change to the study record itself.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page's version history.SummaryDifference0.1%

- Check90 days agoChange DetectedUpdated the page revision from v3.4.2 to v3.4.3 in the footer.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.